Activity of propolis from Mexico on the proliferation and virulence factors of Candida albicans.
Anti-opportunistic infection
Natural antifungal agents
Natural products targets
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
04 11 2023
04 11 2023
Historique:
received:
13
04
2023
accepted:
14
10
2023
medline:
6
11
2023
pubmed:
4
11
2023
entrez:
4
11
2023
Statut:
epublish
Résumé
This research evaluated the anti-Candida albicans effect of Mexican propolis from Chihuahua. Chemical composition of the ethanolic extract of propolis was determined by GC-MS, HPLC-DAD, and HPLC-MS. The presence of anthraquinone, aromatic acid, fatty acids, flavonoids, and carbohydrates was revealed. The anti-Candida activity of propolis was determined. The inhibitions halos were between 10.0 to 11.8 mm; 25% minimum inhibitory concentration (0.5 mg/ml) was fungistatic, and 50% minimum inhibitory concentration (1.0 mg/ml) was fungicidal. The effect of propolis on the capability of C. albicans to change its morphology was evaluated. 25% minimum inhibitory concentration inhibited to 50% of germ tube formation. Staining with calcofluor-white and propidium iodide was performed, showing that the propolis affected the integrity of the cell membrane. INT1 gene expression was evaluated by qRT-PCR. Propolis significantly inhibited the expression of the INT1 gene encodes an adhesin (Int1p). Chihuahua propolis extract inhibited the proliferation of Candida albicans, the development of the germ tube, and the synthesis of adhesin INT1. Given the properties demonstrated for Chihuahua propolis, we propose that it is a candidate to be considered as an ideal antifungal agent to help treat this infection since it would not have the toxic effects of conventional antifungals.
Sections du résumé
BACKGROUND
This research evaluated the anti-Candida albicans effect of Mexican propolis from Chihuahua. Chemical composition of the ethanolic extract of propolis was determined by GC-MS, HPLC-DAD, and HPLC-MS. The presence of anthraquinone, aromatic acid, fatty acids, flavonoids, and carbohydrates was revealed.
RESULTS
The anti-Candida activity of propolis was determined. The inhibitions halos were between 10.0 to 11.8 mm; 25% minimum inhibitory concentration (0.5 mg/ml) was fungistatic, and 50% minimum inhibitory concentration (1.0 mg/ml) was fungicidal. The effect of propolis on the capability of C. albicans to change its morphology was evaluated. 25% minimum inhibitory concentration inhibited to 50% of germ tube formation. Staining with calcofluor-white and propidium iodide was performed, showing that the propolis affected the integrity of the cell membrane. INT1 gene expression was evaluated by qRT-PCR. Propolis significantly inhibited the expression of the INT1 gene encodes an adhesin (Int1p). Chihuahua propolis extract inhibited the proliferation of Candida albicans, the development of the germ tube, and the synthesis of adhesin INT1.
CONCLUSIONS
Given the properties demonstrated for Chihuahua propolis, we propose that it is a candidate to be considered as an ideal antifungal agent to help treat this infection since it would not have the toxic effects of conventional antifungals.
Identifiants
pubmed: 37924042
doi: 10.1186/s12866-023-03064-9
pii: 10.1186/s12866-023-03064-9
pmc: PMC10625287
doi:
Substances chimiques
Propolis
9009-62-5
Virulence Factors
0
Antifungal Agents
0
Plant Extracts
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
325Informations de copyright
© 2023. The Author(s).
Références
Toxicol Appl Pharmacol. 2014 Aug 15;279(1):1-7
pubmed: 24848621
J Oral Biosci. 2021 Jun;63(2):120-128
pubmed: 33839266
Biomed Pharmacother. 2021 May;137:111345
pubmed: 33556873
J Nephropharmacol. 2015 Jan 01;4(1):27-30
pubmed: 28197471
Folia Histochem Cytobiol. 2012 Apr 24;50(1):25-37
pubmed: 22532133
J Chem Ecol. 2023 Aug;49(7-8):408-417
pubmed: 37097511
Genes (Basel). 2018 Sep 19;9(9):
pubmed: 30235884
Microorganisms. 2020 Jan 22;8(2):
pubmed: 31979032
Antibiotics (Basel). 2020 Jan 26;9(2):
pubmed: 31991883
Trends Microbiol. 1998 Aug;6(8):300-1; discussion 302-3
pubmed: 9746938
Am J Med. 2012 Jan;125(1 Suppl):S3-13
pubmed: 22196207
3 Biotech. 2019 Jan;9(1):37
pubmed: 30622875
Neurosci Lett. 2003 Mar 13;339(1):62-6
pubmed: 12618301
Braz Oral Res. 2015;29:
pubmed: 26154370
Microorganisms. 2022 Feb 04;10(2):
pubmed: 35208818
Antibiotics (Basel). 2020 Jul 25;9(8):
pubmed: 32722455
Mediators Inflamm. 2020 Apr 21;2020:5062506
pubmed: 32377161
Biomed Res Int. 2013;2013:102918
pubmed: 23841050
Molecules. 2021 May 14;26(10):
pubmed: 34069165
Arch Oral Biol. 2017 Apr;76:76-83
pubmed: 27659902
Int J Environ Health Res. 2022 Aug 11;:1-13
pubmed: 35951754
Foods. 2021 Jun 11;10(6):
pubmed: 34208334
Rev Iberoam Micol. 2022 Apr-Jun;39(2):50-53
pubmed: 35701335
Microorganisms. 2020 Jun 06;8(6):
pubmed: 32517179
Molecules. 2018 Feb 06;23(2):
pubmed: 29415430
Molecules. 2021 Jun 26;26(13):
pubmed: 34206940
Virulence. 2013 Feb 15;4(2):119-28
pubmed: 23302789
Virulence. 2015;6(4):307-8
pubmed: 25590793
Mediators Inflamm. 2007;2007:45673
pubmed: 18274639
J Ethnopharmacol. 2020 Jun 28;256:112791
pubmed: 32234352
Molecules. 2020 Jan 28;25(3):
pubmed: 32012913
Science. 1998 Feb 27;279(5355):1355-8
pubmed: 9478896
Molecules. 2022 Jan 01;27(1):
pubmed: 35011491
Biochim Biophys Acta. 2012 Oct;1820(10):1463-8
pubmed: 22609876
J Agric Food Chem. 2010 Jan 13;58(1):194-201
pubmed: 19916546
Mini Rev Med Chem. 2016;16(7):555-78
pubmed: 26776224
J Antimicrob Chemother. 2006 Nov;58(5):942-9
pubmed: 16973655
Evid Based Complement Alternat Med. 2018 Mar 11;2018:4360356
pubmed: 29713363
Evid Based Complement Alternat Med. 2018 Aug 6;2018:7092416
pubmed: 30174714
Antioxidants (Basel). 2020 Jan 13;9(1):
pubmed: 31940981
Toxins (Basel). 2022 Mar 03;14(3):
pubmed: 35324685
Amino Acids. 2021 Jul;53(7):961-991
pubmed: 34081205
J Ethnopharmacol. 2007 Jul 25;112(3):476-81
pubmed: 17537602
J Fungi (Basel). 2020 Nov 27;6(4):
pubmed: 33261213
Annu Rev Microbiol. 2015;69:71-92
pubmed: 26488273
Chem Cent J. 2014 May 02;8:28
pubmed: 24812573
Adv Pharmacol Sci. 2013;2013:308249
pubmed: 24382957
Future Med Chem. 2018 May 1;10(9):987-1002
pubmed: 29683339
Front Microbiol. 2022 Jun 16;13:911322
pubmed: 35783432
J Basic Microbiol. 2009 Dec;49(6):579-83
pubmed: 19810039
J Agric Food Chem. 2001 Jun;49(6):2774-9
pubmed: 11409965
Curr Drug Targets. 2022;23(2):116-125
pubmed: 34551694